Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Pollak, Julia ^a   Rai, Karan G ^a   Funk, Cory C ^b   Arora, Sonali ^c   Lee, Eunjee ^d   Zhu, Jun ^d   Price, Nathan D ^b   Paddison, Patrick J ^c   Ramirez, Jan Marino ^a,e   Rostomily, Robert C ^e,f,g  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^g HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GAP JUNCTION PROTEIN; GLUTAMATE RECEPTOR 3; ION CHANNEL; POTASSIUM CHANNEL KV1.2; SODIUM CHANNEL NAV1.6; ANTINEOPLASTIC AGENT; TRANSCRIPTOME;

ADULT; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOGENESIS; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FETUS; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; RNA SEQUENCE; SURVIVAL TIME; TRANSCRIPTOMICS; WHOLE EXOME SEQUENCING; BRAIN NEOPLASMS; CANCER STEM CELL; CELL SURVIVAL; CLUSTER ANALYSIS; DRUG EFFECTS; GAP JUNCTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CLUSTER ANALYSIS; GAP JUNCTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; ION CHANNELS; NEOPLASTIC STEM CELLS; PROGNOSIS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TRANSCRIPTOME; TREATMENT OUTCOME;

EID: 85014735423     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0172884     Document Type: Article

References (69)

1. Wen PY, Kesari S. Malignant Gliomas in Adults. N Engl J Med 2008; 359:492-507. doi: 10.1056/NEJMra0708126 PMID: 18669428
2. Huse JT, Holland EC. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat. Rev. Cancer 2010; 10:319-31. doi: 10.1038/nrc2818 PMID: 20414201
3. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63:5821-8. PMID: 14522905
4. Singh SK, Hawkins C, Clarke ID, Squire J a, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004; 432:396-401. doi: 10.1038/nature03128 PMID: 15549107
5. Das S, Srikanth M, Kessler JA. Cancer stem cells and glioma. Nat. Clin. Pract. Neurol. 2008; 4:427-35. doi: 10.1038/ncpneuro0862 PMID: 18628751
6. Chen J, Li Y, Yu T-S, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012; 488:522-6. doi: 10.1038/nature11287 PMID: 22854781
7. Hille B. Chapter 1 Introduction. In: Ion Channels of Excitable Membranes. Sunderland, Massachusetts: Sinauer Associates, Inc.; 2001. page 1-22.
8. Gadsby DC. Ion channels versus ion pumps: the principal difference, in principle. Nat Rev Mol Cell Biol 2009; 10:344-52. doi: 10.1038/nrm2668 PMID: 19339978
9. Litan A, Langhans SA. Cancer as a channelopathy: ion channels and pumps in tumor development and progression. Front. Cell. Neurosci. 2015; 9:1-11.
10. Becchetti A. Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. Am. J. Physiol. Cell Physiol. 2011; 301:C255-65. doi: 10.1152/ajpcell.00047.2011 PMID: 21430288
11. Cuddapah VA, Sontheimer H. Ion channels and transporters in cancer. 2. Ion channels and the control of cancer cell migration. Am J Physiol Cell Physiol 2011; 301:C541-9. doi: 10.1152/ajpcell.00102.2011 PMID: 21543740
12. Lehen'kyi V, Shapovalov G, Skryma R, Prevarskaya N. Ion channnels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis. Am. J. Physiol. Cell Physiol. 2011; 301:C1281-1289. doi: 10.1152/ajpcell.00249.2011 PMID: 21940667
13. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti A. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 2009; 16:66-93. PMID: 19149563
14. Leanza L, Managò A, Zoratti M, Gulbins E, Szabo I. Pharmacological targeting of ion channels for cancer therapy: In vivo evidences. Biochim. Biophys. Acta 2015; 1863:1385-97. doi: 10.1016/j.bbamcr. 2015.11.032 PMID: 26658642
15. Sontheimer H. An unexpected role for ion channels in brain tumor metastasis. Exp. Biol. Med. 2008; 233:779-91.
16. Wang C, Funk CC, Eddy JA, Price ND. Transcriptional Analysis of Aggressiveness and Heterogeneity across Grades of Astrocytomas. PLoS One 2013; 8:e76694. doi: 10.1371/journal.pone.0076694 PMID: 24146911
17. Simon OJ, Müntefering T, Grauer OM, Meuth SG. The role of ion channels in malignant brain tumors. J. Neurooncol. 2015; 125:225-35. doi: 10.1007/s11060-015-1896-9 PMID: 26334315
18. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme. Science (80-.). 2008; 321:1807-12.
19. Joshi AD, Parsons DW, Velculescu VE, Riggins GJ. Sodium ion channel mutations in glioblastoma patients correlate with shorter survival. Mol. Cancer 2011; 10:1-9.
20. Cuddapah VA, Robel S, Watkins S, Sontheimer H. A neurocentric perspective on glioma invasion. Nat. Rev. Neurosci. 2014; 15:455-65. doi: 10.1038/nrn3765 PMID: 24946761
21. Weaver AK, Liu X, Sontheimer H. Role for Calcium-Activated Potassium Channels (BK) in Growth Control of Human Malignant Glioma Cells. J. Neurosci. Res. 2004; 234:224-34.
22. Alexander SPH, Catterall WA, Kelly E, Marrion N, Peters JA, Benson HE, et al. The Concise Guide to Pharmacology 2015/16: Overview. Br. J. Pharmacol. 2015; 172:5729-5743. doi: 10.1111/bph.13347 PMID: 26650438
23. Cong D, Zhu W, Kuo JS, Hu S, Sun D. Ion transporters in brain tumors. Curr Med Chem 2015; 22: 37-54.
24. Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Horstmann H, et al. Brain tumor cells interconnect to a functional and resistant network. Nature 2015; 528:93-8. doi: 10.1038/nature16071 PMID: 26536111
25. Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, et al. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. Neuron 2016; 89:1-17.
26. Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17:98-110. doi: 10.1016/j.ccr.2009.12.020 PMID: 20129251
27. Toledo CM, Ding Y, Hoellerbauer P, Davis RJ, Basom R, Girard EJ, et al. Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells. Cell Rep. 2015; 13:2425-39. doi: 10.1016/j.celrep.2015.11.021 PMID: 26673326
28. McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis GM, Olson JJ et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455:1061-8. doi: 10.1038/nature07385 PMID: 18772890
29. Ivy GAP Ivy Glioblastoma Atlas Project. 2015.
30. Gilbertson RJ, Rich JN. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat. Rev. Cancer 2007; 7:733-6. doi: 10.1038/nrc2246 PMID: 17882276
31. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007; 11:69-82. doi: 10.1016/j.ccr.2006.11.020 PMID: 17222791
32. Blackiston DJ, McLaughlin KA, Levin M. Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle. Cell Cycle 2009; 8:3519-28.
33. Son MJ, Woolard K, Nam D-H, Lee J, Fine HA. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009; 4:440-52. doi: 10.1016/j.stem.2009.03.003 PMID: 19427293
34. Wang R, Gurguis CI, Gu W, Ko EA, Lim I, Bang H, et al. Ion channel gene expression predicts survival in glioma patients. Sci. Rep. 2015; 5:1-10.
35. Besson P, Driffort V, Bon É, Gradek F, Chevalier S, Roger S. How do voltage-gated sodium channels enhance migration and invasiveness in cancer cells? Biochim. Biophys. Acta-Biomembr. 2015; 1848:2493-501.
36. Brackenbury W. Voltage-gated sodium channels and metastatic disease. Channels 2012; 6:352-61. doi: 10.4161/chan.21910 PMID: 22992466
37. Pardo LA, Stühmer W. The roles of K+ channels in cancer. Nat. Rev. Cancer 2014; 14:39-48. doi: 10.1038/nrc3635 PMID: 24336491
38. Turner KL, Sontheimer H. Cl- and K+ channels and their role in primary brain tumour biology. Philos. Trans. R. Soc. B Biol. Sci. 2014; 369:20130095-20130095.
39. Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat. Rev. Drug Discov. 2006; 5:993-6. doi: 10.1038/nrd2199 PMID: 17139284
40. Olsen ML, Sontheimer H. Functional implications for Kir4.1 channels in glial biology: from K+ buffering to cell differentiation. J Neurochem 2008; 107:589-601. doi: 10.1111/j.1471-4159.2008.05615.x PMID: 18691387
41. Liu X, Chang Y, Reinhart PH, Sontheimer H. Cloning and Characterization of Glioma BK, a Novel BK Channel Isoform Highly Expressed in Human Glioma Cells. 2002; 22:1840-9.
42. Ouadid-Ahidouch H, Rodat-Despoix L, Matifat F, Morin G, Ahidouch A. DNA methylation of channelrelated genes in cancers. Biochim. Biophys. Acta 2015; 1848:2621-8. doi: 10.1016/j.bbamem.2015.02. 015 PMID: 25703813
43. Xia J, Zhou Z-H, Bubien JK, Fuller CM, Markert JM, Mapstone TB, et al. Molecular cloning and characterization of human acid sensing ion channel (ASIC)2 gene promoter. Gene 2003; 313:91-101. PMID: 12957380
44. Pla AF, Avanzato D, Munaron L, Ambudkar IS. Ion channels and transporters in cancer. 6. Vascularizing the tumor: TRP channels as molecular targets. AJP Cell Physiol. 2012; 302:C9-15.
45. Rao V, Perez-Neut M, Kaja S, Gentile S. Voltage-Gated Ion Channels in Cancer Cell Proliferation. Cancers (Basel). 2015; 7:849-75.
46. Urrego D, Tomczak AP, Zahed F, Stühmer W, Pardo LA. Potassium channels in cell cycle and cell proliferation. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2014; 369:20130094. doi: 10.1098/rstb.2013.0094 PMID: 24493742
47. Blackiston DJ, McLaughlin K a., Levin M. Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle. Cell Cycle 2009; 8:3519-28.
48. Yang M, Brackenbury WJ. Membrane potential and cancer progression. Front. Physiol. 2013; 4:1-10.
49. Stillwell EF, Cone CM C C. Stimulation of DNA synthesis in CNS neurones by sustained depolarisation. Nat. New Biol. 1973; 246:110-1. PMID: 4518935
50. Cone CD. The role of the surface electrical transmembrane potential in normal and malignant mitogenesis. Ann. N. Y. Acad. Sci. 1974; 238:420-35. PMID: 4613241
51. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9:391-403. doi: 10.1016/j.ccr.2006.03.030 PMID: 16697959
52. Joo KM, Kim J, Jin J, Kim M, Seol HJ, Muradov J, et al. Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. Cell Rep. 2013; 3:260-73. doi: 10.1016/j.celrep.2012.12.013 PMID: 23333277
53. Liu Z, Zhao X, Mao H, Baxter PA, Huang Y, Yu L, et al. Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel. Neuro. Oncol. 2013; 15:1173-85. doi: 10.1093/neuonc/not065PMID: 23658322
54. Engström PG, Tommei D, Stricker SH, Ender C, Pollard SM, Bertone P. Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival. Genome Med. 2012; 4:1-19.
55. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009; 4:568-80. doi: 10.1016/j.stem.2009.03.014 PMID: 19497285
56. Sun Y, Pollard S, Conti L, Toselli M, Biella G, Parkin G, et al. Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol. Cell. Neurosci. 2008; 38:245-58. doi: 10.1016/j.mcn.2008.02.014 PMID: 18450476
57. Sonoda Y, Ozawa T, Hirose Y, Aldape KD, Mcmahon M, Berger MS, et al. Formation of Intracranial Tumors by Genetically Modified Human Astrocytes Defines Four Pathways Critical in the Development of Human Anaplastic Astrocytoma. Cancer Res. 2001; 53:4956-60.
58. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15:550. doi: 10.1186/s13059-014-0550-8 PMID: 25516281
59. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013; 14:1-13.
60. Anders S, Pyl PT, Huber W. HTSeq-A Python framework to work with high-throughput sequencing data. Bioinformatics 2015; 31:166-9. doi: 10.1093/bioinformatics/btu638 PMID: 25260700
61. Robinson MD, McCarthy DJ, Smyth GK. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010; 26:139-40. doi: 10.1093/bioinformatics/btp616 PMID: 19910308
62. Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpharesponsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003; 34:267-73. doi: 10.1038/ng1180 PMID: 12808457
63. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005; 102:15545-50. doi: 10.1073/pnas.0506580102 PMID: 16199517
64. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9:157-73. doi: 10.1016/j.ccr.2006.02.019 PMID: 16530701
65. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006; 7:96. doi: 10.1186/1471-2164-7-96 PMID: 16643655
66. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20:1297-1303. doi: 10.1101/gr.107524.110 PMID: 20644199
67. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010; 26:589-95. doi: 10.1093/bioinformatics/btp698 PMID: 20080505
68. Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w 1118; iso-2; iso-3. Fly (Austin). 2012; 6:80-92.
69. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A a, Kim S, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Supp. Nature 2012; 483: 603-7. doi: 10.1038/nature11003 PMID: 22460905